ArticleCrohn's & colitis 3602021

Switching from Infliximab to Biosimilar in Inflammatory Bowel Disease: A Review of Existing Literature and Best Practices.

Shubha Bhat et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.